DeepMed Research

Oregon Health and Science University

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

The Effects of a Prostaglandin Inhibitor on Ovulation and the Menstrual Cycle

Not Applicable

Completed

Conditions: Ovulation (Follicular Rupture Yes/no)
Menstrual Cycles (Total Length, Bleeding Days)
Gonadotropin and Ovarian Hormone Levels (FSH, LH, E2, P)

Interventions: Drug: Celebrex
Drug: Placebo

First Posted Date: 2008-02-13

Last Posted Date: 2012-12-13

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 11

Registration Number: NCT00614406

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

Intrauterine Lidocaine Infusion for Essure Sterilization Procedures

Phase 4

Completed

Conditions: Pain

Interventions: Drug: Lidocaine
Drug: Sterile Saline

First Posted Date: 2008-02-13

Last Posted Date: 2019-12-19

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 58

Registration Number: NCT00613834

Locations: 🇺🇸
Planned Parenthood of the Columbia Willamette, Portland, Oregon, United States
🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

Misoprostol With Intrauterine Device Insertion

Not Applicable

Completed

Conditions: Contraception

Interventions: Dietary Supplement: Magnesium Oxide
Drug: Misoprostol

First Posted Date: 2008-02-13

Last Posted Date: 2013-03-15

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 40

Registration Number: NCT00613366

Locations: 🇺🇸
Planned Parenthood of the Columbia Willamette, Portland, Oregon, United States
🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

Hormonal Contraception and Vaginal Health

Not Applicable

Completed

Conditions: Contraceptive Usage
Vaginal Epithelial Disruption

Interventions: Drug: Desogen (ethinyl estradiol and desogestrel)
Drug: NuvaRing (ethinyl estradiol and etonogestrel)

First Posted Date: 2008-02-11

Last Posted Date: 2012-11-08

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 14

Registration Number: NCT00612508

Locations: 🇺🇸
Oregon Health and Science University, Portland, Oregon, United States

Centella Asiatica Selected Triterpenes (CAST) for Diabetic Neuropathy

Phase 2

Completed

Conditions: Diabetic Neuropathy

Interventions: Drug: Centella asiatica selected triterpenes (CAST)
Other: Placebo

First Posted Date: 2008-02-06

Last Posted Date: 2012-11-12

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 43

Registration Number: NCT00608439

Locations: 🇺🇸
Oregon Health and Science University, Portland, Oregon, United States

Clinical Trial of Acamprosate for Tinnitus

Phase 1

Completed

Conditions: Tinnitus

Interventions: Drug: Placebo
Drug: Acamprosate

First Posted Date: 2008-01-17

Last Posted Date: 2016-11-08

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 154

Registration Number: NCT00596531

Locations: 🇺🇸
OHSU, Portland, Oregon, United States

Lutein and Alzheimer's Disease Study

Phase 2

Terminated

Conditions: Alzheimer's Disease

Interventions: Dietary Supplement: lutein/zeaxanthin
Dietary Supplement: placebo

First Posted Date: 2008-01-16

Last Posted Date: 2019-08-12

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 3

Registration Number: NCT00596024

Locations: 🇺🇸
Oregon Health and Science University, Portland, Oregon, United States

The Influence of Probiotics on Vancomycin-Resistant Enterococcus

Not Applicable

Terminated

Conditions: GI Colonization of Vancomycin-resistant Enterococcus

Interventions: Dietary Supplement: yogurt
Dietary Supplement: probiotics

First Posted Date: 2008-01-11

Last Posted Date: 2019-06-04

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 8

Registration Number: NCT00591474

Locations: 🇺🇸
OHSU hospital, Portland, Oregon, United States

Study of Endoscopic Barrett's Esophagus Diagnosis

Terminated

Conditions: GERD
Barrett's Esophagus

First Posted Date: 2008-01-11

Last Posted Date: 2019-12-11

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 13

Registration Number: NCT00591461

Locations: 🇺🇸
PVAMC, Portland, Oregon, United States
🇺🇸
OHSU, Portland, Oregon, United States

Safety Study Of N-Acetylcysteine For Prevention Of Contrast Induced Nephropathy In Patients w/Stage 3 Renal Failure

Phase 1

Terminated

Conditions: Contrast Induced Nephropathy

Interventions: Drug: N-acetylcysteine

First Posted Date: 2007-12-18

Last Posted Date: 2019-08-02

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 6

Registration Number: NCT00575419

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy